Thus, once ignited, the AβPP-independent iAβ production pathway (the “AD Engine”) renders the AβPP proteolytic pathway irrelevant to the progression of AD and makes any attempt at the therapeutic utilization of the ACH-based drugs futile. The gene discussed is APP; the disease is Alzheimer disease.